Industry Research Reports
Home > Reports > New Technology > Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Key Findings
In 2025, global production of Kidney-Organ Chip was approximately 22,599 units.
Commercial models concentrate on proximal tubule and nephrotoxicity applications
Human cells and controlled perfusion improve renal physiological relevance
Drug developers and research institutions remain the primary customer groups
Assay-ready systems reduce operational barriers for pharmaceutical laboratories
Standardization and regulatory validation determine long-term market scalability
Kidney-Organ Chip Market Size(US$)
CAGR 2026-2032
10.5%
Market Size,2032
USD 73.18
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 40.18 million
Market Forecast in 2032(Value)
US$ 73.18 million
CAGR
10.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.
Market Trends
Kidney-Organ Chip technology is progressing from basic single-channel cell-culture devices toward multicellular, vascularized, organoid-based, and interconnected renal models. Developers increasingly use human primary cells, immortalized renal cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived organoids to improve physiological relevance. Dynamic perfusion and controlled shear stress support cell polarity, transporter expression, and long-term renal function. Another major trend is the development of standardized, microplate-compatible products that support automated liquid handling, high-content imaging, and medium- to high-throughput compound testing. Cell-loaded assay-ready models are becoming more important because they reduce model-establishment time and operator-dependent variability. Integrated sensors, real-time imaging, artificial-intelligence-assisted analysis, and transcriptomic or proteomic measurements are expanding functional readouts. Multi-organ configurations linking the kidney with the liver, intestine, heart, muscle, or immune system are also gaining attention for evaluating drug metabolism, systemic exposure, renal clearance, and inter-organ toxicity. These developments are gradually moving Kidney-Organ Chips from academic prototypes toward practical preclinical tools.
Market Segmentation
By Company
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Draper Laboratory
- Nortis
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Glomerular Chip
- Renal Tubule Chip
- Colliding Duct Chip
Segment by Application
- Hospitals
- Research Institutions
- Universities
- Others
Segment by Category
- Membrane-Based Dual-Channel Type
- 3D Matrix-Embedded Tubular Type
Segment by Division
- Primary Human Cell-Based Type
- Immortalized Cell Line-Based Type
- Stem Cell & Organoid-Based Type
Market Dynamics
Drivers
The primary market driver is the need to detect drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can result in program termination, clinical failure, restricted dosing, additional monitoring requirements, or post-market safety concerns. Conventional models may not reproduce the polarity, transporter activity, fluid flow, and epithelial-vascular interactions of the human kidney. Kidney-Organ Chips provide controlled environments for measuring drug exposure, secretion, reabsorption, permeability, biomarker release, and tissue injury over time. Growing research activity in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited renal disorders is also expanding demand for human disease models. Additional growth factors include advances in microfluidics, stem-cell differentiation, organoid culture, three-dimensional tissue engineering, and automated imaging. Policies promoting alternatives to animal testing and pharmaceutical investment in human-relevant models further support adoption. Together, these drivers are extending Kidney-Organ Chip use from academic research to mechanistic toxicology, compound screening, translational studies, and preclinical decision support.
Restraints
Commercial expansion is restrained by the biological complexity of the kidney and the lack of universally accepted validation standards. The kidney contains multiple nephron segments, specialized epithelial cells, endothelial cells, stromal cells, immune components, and complex vascular structures responsible for filtration, secretion, reabsorption, concentration, and endocrine regulation. Most commercial models reproduce only selected functions rather than the complete organ. Human primary renal cells may exhibit donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic systems may experience bubbles, evaporation, contamination, inconsistent flow, material absorption, and operational complexity. Customers can also require specialized pumps, imaging equipment, analytical methods, and trained personnel. Differences in chip geometry, cell type, extracellular matrix, medium, flow rate, exposure protocol, and endpoint selection reduce comparability between platforms. Until reference compounds, performance criteria, interlaboratory studies, and regulatory pathways become more established, Kidney-Organ Chips will mainly complement rather than completely replace existing preclinical methods.
Opportunities
The strongest commercial opportunities lie in standardized and assay-ready Kidney-Organ Chip models that provide reproducible results with limited user preparation. Pharmaceutical companies require scalable platforms for nephrotoxicity screening, renal transporter analysis, biomarker assessment, compound prioritization, and mechanism-of-injury studies. Disease-specific models constructed from patient-derived cells or induced pluripotent stem cells offer opportunities in rare kidney diseases, inherited disorders, precision medicine, and individualized therapeutic development. Multi-organ systems connecting the kidney with the liver, intestine, muscle, heart, or immune system can support pharmacokinetic, metabolism, systemic toxicity, and organ-interaction studies. Suppliers can also expand through customized model development, contract testing, data analysis, regulatory consulting, software, training, and cell-and-reagent packages. Compatibility with automated laboratory workflows and standard microplate formats could accelerate adoption by large pharmaceutical organizations. China, Japan, and South Korea offer additional opportunities through expanding biopharmaceutical research, microfluidic manufacturing capabilities, organoid programs, and policies supporting alternatives to animal testing. Partnerships with contract research organizations and cell suppliers can further strengthen market access.
Challenges
The principal challenge is generating biologically meaningful and repeatable data suitable for pharmaceutical and regulatory decisions. Renal cells must maintain appropriate polarity, transporter expression, barrier integrity, metabolic activity, and responses to physiological flow throughout the required culture period. Variations in cell source, extracellular matrix, medium composition, chip material, flow conditions, and dosing procedures can materially affect results. Developers must also establish clinically relevant endpoints, including transport activity, permeability, morphology, gene expression, tissue-injury biomarkers, and recovery responses. Scaling from laboratory prototypes to standardized commercial products requires consistent microfabrication, membrane quality, surface treatment, sterilization, cell loading, packaging, storage, and shipment. Another challenge is balancing physiological complexity with throughput and operational simplicity. Highly complex vascularized or multi-organ models may offer stronger biological relevance but can be more difficult and expensive to operate. Wider adoption will require reference-compound testing, transparent performance benchmarks, standardized data formats, interlaboratory validation, and clearer regulatory acceptance of Kidney-Organ Chip evidence.
Industry Chain Analysis
The upstream industry includes microfluidic polymers, glass substrates, porous membranes, extracellular matrices, surface coatings, renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. The quality of these inputs directly influences cell viability, flow stability, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture microfluidic chips, integrate perfusion equipment, construct renal tissue models, optimize culture protocols, develop analytical software, validate biological functions, and provide assay-ready products or customized testing services. Their competitiveness depends on combining microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical companies, cosmetics companies, and regulatory research institutions. Products reach customers through direct technical sales, specialized scientific distributors, collaborative development agreements, and contract-service models. Installation, training, model development, data interpretation, software support, and consumable supply constitute an important service layer.
Segment Insights
By simulated renal structure, Kidney-Organ Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models represent the most commercially developed segment because they support nephrotoxicity, secretion, reabsorption, and transporter studies. By technical architecture, the market includes membrane-based dual-channel devices, three-dimensional matrix-embedded tubular models, organoid-on-chip platforms, vascularized renal models, and bioprinted chips. By product form, products can be classified into blank chips and consumables, cell-loaded assay-ready models, perfusion instruments and complete systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major applications include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic and ADME analysis, and personalized medicine. Selection depends on biological complexity, throughput, repeatability, operating difficulty, and required analytical endpoints.
Downstream Market Opportunities
Drug-induced nephrotoxicity testing represents the leading downstream opportunity because pharmaceutical developers need to identify compounds that damage glomerular, tubular, vascular, or interstitial tissues before clinical trials. Kidney-Organ Chips can support dose-response analysis, compound ranking, transporter studies, biomarker evaluation, and investigation of injury mechanisms. Renal disease modeling offers opportunities in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Drug-transport and clearance models can improve understanding of secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ systems enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized therapy selection. Pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions are the primary customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional demand for renal toxicity assessment.
Regional Insights
North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.
Fastest-Growing Region: Asia Pacific
North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
By Type,2021-2032(US$ Million)
Glomerular Chip
Renal Tubule Chip
Colliding Duct Chip
By Application，2021-2032(US$ Million）
Hospitals
Research Institutions
Universities
Others
Competitive Landscape Analysis
The competitive landscape includes dedicated Kidney-Organ Chip suppliers, broader organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules through its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating kidney tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney-Organ Chip development, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or renal-model solutions. Asian participants include Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio. Competitive differentiation centers on renal physiological relevance, validated function, reproducibility, throughput, ease of use, cell quality, automation, data analysis, application support, and regulatory credibility rather than on microfluidic-chip production capacity alone.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Kidney-Organ Chip market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Chapter Outline
Chapter 1: Defines the Kidney-Organ Chip study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Introduction to Kidney-Organ Chip: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Kidney-Organ Chip Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Glomerular Chip
1.2.3 Renal Tubule Chip
1.2.4 Colliding Duct Chip
1.3 Market Segmentation by Structure
1.3.1 Global Kidney-Organ Chip Market Size by Structure, 2021 vs 2025 vs 2032
1.3.2 Membrane-Based Dual-Channel Type
1.3.3 3D Matrix-Embedded Tubular Type
1.4 Market Segmentation by Source
1.4.1 Global Kidney-Organ Chip Market Size by Source, 2021 vs 2025 vs 2032
1.4.2 Primary Human Cell-Based Type
1.4.3 Immortalized Cell Line-Based Type
1.4.4 Stem Cell & Organoid-Based Type
1.5 Market Segmentation by Application
1.5.1 Global Kidney-Organ Chip Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Research Institutions
1.5.4 Universities
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Kidney-Organ Chip Revenue Estimates and Forecasts (2021-2032)
2.2 Global Kidney-Organ Chip Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Kidney-Organ Chip Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Kidney-Organ Chip Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Glomerular Chip: Market Share by Key Players
3.3.2 Renal Tubule Chip: Market Share by Key Players
3.3.3 Colliding Duct Chip: Market Share by Key Players
3.4 Global Kidney-Organ Chip Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Kidney-Organ Chip Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Kidney-Organ Chip Market by Structure
4.2.1 Global Revenue by Structure (2021-2032)
4.2.2 Global Revenue-Based Market Share by Structure (2021-2032)
4.3 Global Kidney-Organ Chip Market by Source
4.3.1 Global Revenue by Source (2021-2032)
4.3.2 Global Revenue-Based Market Share by Source (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Kidney-Organ Chip Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Kidney-Organ Chip Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Kidney-Organ Chip Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Kidney-Organ Chip Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Kidney-Organ Chip Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Kidney-Organ Chip Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Kidney-Organ Chip Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Kidney-Organ Chip Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Kidney-Organ Chip Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Kidney-Organ Chip Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Kidney-Organ Chip Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Emulate
11.1.1 Emulate Corporation Information
11.1.2 Emulate Business Overview
11.1.3 Emulate Kidney-Organ Chip Product Features and Attributes
11.1.4 Emulate Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.1.5 Emulate Kidney-Organ Chip Revenue by Product in 2025
11.1.6 Emulate Kidney-Organ Chip Revenue by Application in 2025
11.1.7 Emulate Kidney-Organ Chip Revenue by Geographic Area in 2025
11.1.8 Emulate Kidney-Organ Chip SWOT Analysis
11.1.9 Emulate Recent Developments
11.2 Mimetas
11.2.1 Mimetas Corporation Information
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Kidney-Organ Chip Product Features and Attributes
11.2.4 Mimetas Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.2.5 Mimetas Kidney-Organ Chip Revenue by Product in 2025
11.2.6 Mimetas Kidney-Organ Chip Revenue by Application in 2025
11.2.7 Mimetas Kidney-Organ Chip Revenue by Geographic Area in 2025
11.2.8 Mimetas Kidney-Organ Chip SWOT Analysis
11.2.9 Mimetas Recent Developments
11.3 TissUse
11.3.1 TissUse Corporation Information
11.3.2 TissUse Business Overview
11.3.3 TissUse Kidney-Organ Chip Product Features and Attributes
11.3.4 TissUse Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.3.5 TissUse Kidney-Organ Chip Revenue by Product in 2025
11.3.6 TissUse Kidney-Organ Chip Revenue by Application in 2025
11.3.7 TissUse Kidney-Organ Chip Revenue by Geographic Area in 2025
11.3.8 TissUse Kidney-Organ Chip SWOT Analysis
11.3.9 TissUse Recent Developments
11.4 Valo Health
11.4.1 Valo Health Corporation Information
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Kidney-Organ Chip Product Features and Attributes
11.4.4 Valo Health Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.4.5 Valo Health Kidney-Organ Chip Revenue by Product in 2025
11.4.6 Valo Health Kidney-Organ Chip Revenue by Application in 2025
11.4.7 Valo Health Kidney-Organ Chip Revenue by Geographic Area in 2025
11.4.8 Valo Health Kidney-Organ Chip SWOT Analysis
11.4.9 Valo Health Recent Developments
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Corporation Information
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Kidney-Organ Chip Product Features and Attributes
11.5.4 CN Bio Innovations Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.5.5 CN Bio Innovations Kidney-Organ Chip Revenue by Product in 2025
11.5.6 CN Bio Innovations Kidney-Organ Chip Revenue by Application in 2025
11.5.7 CN Bio Innovations Kidney-Organ Chip Revenue by Geographic Area in 2025
11.5.8 CN Bio Innovations Kidney-Organ Chip SWOT Analysis
11.5.9 CN Bio Innovations Recent Developments
11.6 Draper Laboratory
11.6.1 Draper Laboratory Corporation Information
11.6.2 Draper Laboratory Business Overview
11.6.3 Draper Laboratory Kidney-Organ Chip Product Features and Attributes
11.6.4 Draper Laboratory Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.6.5 Draper Laboratory Recent Developments
11.7 Nortis
11.7.1 Nortis Corporation Information
11.7.2 Nortis Business Overview
11.7.3 Nortis Kidney-Organ Chip Product Features and Attributes
11.7.4 Nortis Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.7.5 Nortis Recent Developments
11.8 Xona Microfluidics
11.8.1 Xona Microfluidics Corporation Information
11.8.2 Xona Microfluidics Business Overview
11.8.3 Xona Microfluidics Kidney-Organ Chip Product Features and Attributes
11.8.4 Xona Microfluidics Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.8.5 Xona Microfluidics Recent Developments
11.9 SynVivo
11.9.1 SynVivo Corporation Information
11.9.2 SynVivo Business Overview
11.9.3 SynVivo Kidney-Organ Chip Product Features and Attributes
11.9.4 SynVivo Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.9.5 SynVivo Recent Developments
11.10 Beijing Daxiang Biotech
11.10.1 Beijing Daxiang Biotech Corporation Information
11.10.2 Beijing Daxiang Biotech Business Overview
11.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Product Features and Attributes
11.10.4 Beijing Daxiang Biotech Kidney-Organ Chip Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
12 Kidney-Organ Chip Value Chain and Ecosystem Analysis
12.1 Kidney-Organ Chip Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Kidney-Organ Chip Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Kidney-Organ Chip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Kidney-Organ Chip Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Kidney-Organ Chip Market Size Growth Rate by Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Kidney-Organ Chip Market Size Growth Rate by Source, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Kidney-Organ Chip Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Kidney-Organ Chip Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Kidney-Organ Chip Revenue by Region (US$ Million), 2021-2026
Table 7. Global Kidney-Organ Chip Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Kidney-Organ Chip Revenue by Players (US$ Million), 2021-2026
Table 10. Global Kidney-Organ Chip Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Kidney-Organ Chip Revenue, 2025
Table 13. Global Kidney-Organ Chip Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Kidney-Organ Chip Companies Headquarters
Table 15. Global Kidney-Organ Chip Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Kidney-Organ Chip Revenue by Type (US$ Million), 2021-2026
Table 19. Global Kidney-Organ Chip Revenue by Type (US$ Million), 2027-2032
Table 20. Global Kidney-Organ Chip Revenue by Structure (US$ Million), 2021-2026
Table 21. Global Kidney-Organ Chip Revenue by Structure (US$ Million), 2027-2032
Table 22. Global Kidney-Organ Chip Revenue by Source (US$ Million), 2021-2026
Table 23. Global Kidney-Organ Chip Revenue by Source (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Kidney-Organ Chip Revenue by Application (US$ Million), 2021-2026
Table 26. Global Kidney-Organ Chip Revenue by Application (US$ Million), 2027-2032
Table 27. Kidney-Organ Chip High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Kidney-Organ Chip Growth Accelerators and Market Barriers
Table 31. North America Kidney-Organ Chip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Kidney-Organ Chip Growth Accelerators and Market Barriers
Table 33. Europe Kidney-Organ Chip Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Kidney-Organ Chip Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Kidney-Organ Chip Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Kidney-Organ Chip Investment Opportunities and Key Challenges
Table 37. Central and South America Kidney-Organ Chip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Kidney-Organ Chip Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Kidney-Organ Chip Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Emulate Corporation Information
Table 41. Emulate Description and Major Businesses
Table 42. Emulate Product Features and Attributes
Table 43. Emulate Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Emulate Revenue Proportion by Product in 2025
Table 45. Emulate Revenue Proportion by Application in 2025
Table 46. Emulate Revenue Proportion by Geographic Area in 2025
Table 47. Emulate Kidney-Organ Chip SWOT Analysis
Table 48. Emulate Recent Developments
Table 49. Mimetas Corporation Information
Table 50. Mimetas Description and Major Businesses
Table 51. Mimetas Product Features and Attributes
Table 52. Mimetas Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Mimetas Revenue Proportion by Product in 2025
Table 54. Mimetas Revenue Proportion by Application in 2025
Table 55. Mimetas Revenue Proportion by Geographic Area in 2025
Table 56. Mimetas Kidney-Organ Chip SWOT Analysis
Table 57. Mimetas Recent Developments
Table 58. TissUse Corporation Information
Table 59. TissUse Description and Major Businesses
Table 60. TissUse Product Features and Attributes
Table 61. TissUse Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. TissUse Revenue Proportion by Product in 2025
Table 63. TissUse Revenue Proportion by Application in 2025
Table 64. TissUse Revenue Proportion by Geographic Area in 2025
Table 65. TissUse Kidney-Organ Chip SWOT Analysis
Table 66. TissUse Recent Developments
Table 67. Valo Health Corporation Information
Table 68. Valo Health Description and Major Businesses
Table 69. Valo Health Product Features and Attributes
Table 70. Valo Health Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Valo Health Revenue Proportion by Product in 2025
Table 72. Valo Health Revenue Proportion by Application in 2025
Table 73. Valo Health Revenue Proportion by Geographic Area in 2025
Table 74. Valo Health Kidney-Organ Chip SWOT Analysis
Table 75. Valo Health Recent Developments
Table 76. CN Bio Innovations Corporation Information
Table 77. CN Bio Innovations Description and Major Businesses
Table 78. CN Bio Innovations Product Features and Attributes
Table 79. CN Bio Innovations Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. CN Bio Innovations Revenue Proportion by Product in 2025
Table 81. CN Bio Innovations Revenue Proportion by Application in 2025
Table 82. CN Bio Innovations Revenue Proportion by Geographic Area in 2025
Table 83. CN Bio Innovations Kidney-Organ Chip SWOT Analysis
Table 84. CN Bio Innovations Recent Developments
Table 85. Draper Laboratory Corporation Information
Table 86. Draper Laboratory Description and Major Businesses
Table 87. Draper Laboratory Product Features and Attributes
Table 88. Draper Laboratory Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Draper Laboratory Recent Developments
Table 90. Nortis Corporation Information
Table 91. Nortis Description and Major Businesses
Table 92. Nortis Product Features and Attributes
Table 93. Nortis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. Nortis Recent Developments
Table 95. Xona Microfluidics Corporation Information
Table 96. Xona Microfluidics Description and Major Businesses
Table 97. Xona Microfluidics Product Features and Attributes
Table 98. Xona Microfluidics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. Xona Microfluidics Recent Developments
Table 100. SynVivo Corporation Information
Table 101. SynVivo Description and Major Businesses
Table 102. SynVivo Product Features and Attributes
Table 103. SynVivo Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. SynVivo Recent Developments
Table 105. Beijing Daxiang Biotech Corporation Information
Table 106. Beijing Daxiang Biotech Description and Major Businesses
Table 107. Beijing Daxiang Biotech Product Features and Attributes
Table 108. Beijing Daxiang Biotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Beijing Daxiang Biotech Recent Developments
Table 110. Technologies, Platforms and Infrastructure
Table 111. Distributors List
Table 112. Market Trends and Market Evolution
Table 113. Market Drivers and Opportunities
Table 114. Market Challenges, Risks, and Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney-Organ Chip Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Glomerular Chip Product Picture
Figure 3. Renal Tubule Chip Product Picture
Figure 4. Colliding Duct Chip Product Picture
Figure 5. Global Kidney-Organ Chip Market Size Growth Rate by Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Membrane-Based Dual-Channel Type Product Picture
Figure 7. 3D Matrix-Embedded Tubular Type Product Picture
Figure 8. Global Kidney-Organ Chip Market Size Growth Rate by Source, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Primary Human Cell-Based Type Product Picture
Figure 10. Immortalized Cell Line-Based Type Product Picture
Figure 11. Stem Cell & Organoid-Based Type Product Picture
Figure 12. Global Kidney-Organ Chip Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Hospitals
Figure 14. Research Institutions
Figure 15. Universities
Figure 16. Others
Figure 17. Kidney-Organ Chip Report Years Considered
Figure 18. Global Kidney-Organ Chip Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 20. Global Kidney-Organ Chip Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Kidney-Organ Chip Revenue-Based Market Share by Region (2021-2032)
Figure 22. Global Kidney-Organ Chip Revenue-Based Market Share Ranking (2025)
Figure 23. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 24. Glomerular Chip Revenue-Based Market Share by Player in 2025
Figure 25. Renal Tubule Chip Revenue-Based Market Share by Player in 2025
Figure 26. Colliding Duct Chip Revenue-Based Market Share by Player in 2025
Figure 27. Global Kidney-Organ Chip Revenue-Based Market Share by Type (2021-2032)
Figure 28. Global Kidney-Organ Chip Revenue-Based Market Share by Structure (2021-2032)
Figure 29. Global Kidney-Organ Chip Revenue-Based Market Share by Source (2021-2032)
Figure 30. Global Kidney-Organ Chip Revenue-Based Market Share by Application (2021-2032)
Figure 31. North America Kidney-Organ Chip Revenue YoY (US$ Million), 2021-2032
Figure 32. North America Top 5 Players Kidney-Organ Chip Revenue (US$ Million) in 2025
Figure 33. North America Kidney-Organ Chip Revenue (US$ Million) by Application (2021-2032)
Figure 34. US Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 35. Canada Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 36. Mexico Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 37. Europe Kidney-Organ Chip Revenue YoY (US$ Million), 2021-2032
Figure 38. Europe Top 5 Players Kidney-Organ Chip Revenue (US$ Million) in 2025
Figure 39. Europe Kidney-Organ Chip Revenue (US$ Million) by Application (2021-2032)
Figure 40. Germany Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 41. France Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 42. U.K. Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 43. Italy Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 44. Russia Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 45. Asia-Pacific Kidney-Organ Chip Revenue YoY (US$ Million), 2021-2032
Figure 46. Asia-Pacific Top 8 Players Kidney-Organ Chip Revenue (US$ Million) in 2025
Figure 47. Asia-Pacific Kidney-Organ Chip Revenue (US$ Million) by Application (2021-2032)
Figure 48. Indonesia Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 49. Japan Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 50. South Korea Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 51. Australia Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 52. India Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 53. Indonesia Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 54. Vietnam Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 55. Malaysia Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 56. Philippines Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 57. Singapore Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 58. Central and South America Kidney-Organ Chip Revenue YoY (US$ Million), 2021-2032
Figure 59. Central and South America Top 5 Players Kidney-Organ Chip Revenue (US$ Million) in 2025
Figure 60. Central and South America Kidney-Organ Chip Revenue (US$ Million) by Application (2021-2032)
Figure 61. Brazil Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 62. Argentina Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 63. Middle East and Africa Kidney-Organ Chip Revenue YoY (US$ Million), 2021-2032
Figure 64. Middle East and Africa Top 5 Players Kidney-Organ Chip Revenue (US$ Million) in 2025
Figure 65. Middle East and Africa Kidney-Organ Chip Revenue (US$ Million) by Application (2021-2032)
Figure 66. GCC Countries Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 67. Israel Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 68. Egypt Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 69. South Africa Kidney-Organ Chip Revenue (US$ Million), 2021-2032
Figure 70. Kidney-Organ Chip Value Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Related Reports
Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-02-23
Pages: 105
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published Date: 2026-08-02
Pages: 108
USD 4250.00
(Single User License)
Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 110
USD 3950.00
(Single User License)
Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 104
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-02-23
Pages: 105
USD 2900.00 (Single User License)Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-04-26
Pages: 115
USD 4900.00 (Single User License)Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published: 2026-08-02
Pages: 108
USD 4250.00 (Single User License)Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 110
USD 3950.00 (Single User License)Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032
The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 104
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Key Findings
Market Trends
Market Segmentation
Market Dynamics
Industry Chain Analysis
Segment Insights
Downstream Market Opportunities
Regional Insights
Competitive Landscape Analysis
Report Scope
Chapter Outline
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research